Terlipressin Diacetate Salt
中文名称 | Terlipressin Diacetate Salt |
---|---|
中文同义词 | 化合物TERLIPRESSIN ACETATE;双乙酸特利加压素;双醋酸特利加压素;特利加压素二乙酸盐 |
英文名称 | Terlipressin Diacetate Salt |
英文同义词 | Terlipressin Diacetate |
CAS号 | 1884420-36-3 |
分子式 | C54H78N16O17S2 |
分子量 | 1287.43 |
EINECS号 | |
相关类别 | 特利加压素 |
Mol文件 | 1884420-36-3.mol |
结构式 |
Terlipressin Diacetate Salt 性质
溶解度 | 可溶于DMSO(少许)、甲醇(少许) |
---|---|
形态 | 固体 |
颜色 | 白色 |
Vasopressin V1 receptor
Terlipressin (25 nM; 24-72 hours; IEC-6 cells) treatment significantly improves cell viability, proliferation and apoptosis in IEC-6 cells.
Terlipressin inhibits the secretion of TNF-α and 15-F2t-isoprostane from IEC-6 cells following oxygen and glucose deprivation/re-oxygenation (OGD/R). Terlipressin administration following OGD attenuates OGD/R-induced cell damage via the PI3K signaling pathway.
Cell Proliferation Assay
Cell Line: | IEC-6 cells induced by oxygen and glucose deprivation/re-oxygenation (OGD/R) |
Concentration: | 25 nM |
Incubation Time: | 24 hours, 48 hours, 72 hours |
Result: | Significantly increased the proliferation of IEC-6 cells. |
Using a mouse nonlethal hepatic ischemia-reperfusion (IR) model, Terlipressin administration significantly ameliorates IR-induced liver apoptosis, necrosis and inflammation.